Header for print stylesheet
You are here:  
DSM PTG Hires its 100th employee as its business continues to expand
Berkeley,CA,USA,02-Feb-2009

DSM PTG (formerly The Polymer Technology Group/"PTG"), a preeminent biomaterials company, announced today that the Company has recently surpassed the 100 employee mark, necessitated by the robust demand for its proprietary biomaterials and medical device components. The Company also announced that it has appointed two new executives to its management team: Frederik G. Hoogendijk is DSM PTG's Chief Financial Officer (CFO), effective immediately; and, Robert F. Evans assumes the role of Vice President of Global Sales & Marketing, also effective immediately.

Last year the Polymer Technology Group became part of DSM Biomedical. Through this acquisition, the combined companies have achieved a leading position in the field of long-term implantable biomedical polymers along with a technology platform that is applicable to numerous additional materials to address the therapeutic needs of the medical technology industry--ranging from coatings to biomedical materials to drug delivery platforms.

"We are extremely pleased that the robust growth of our biomaterials and medical device components business continues to result in the need for further expansion of our operations, including the hiring of new employees," said Bob Ward, CEO of DSM PTG. "The combined portfolios of the former Polymer Technology Group and DSM Biomedical have resulted in the broadest portfolio of biomedical materials currently available in the worldwide market, and we are very bullish about our future."

Frederik G. Hoogendijk was previously Director of Finance & Control for DSM Fine Chemicals since 2006. He has held a variety of financial control positions with increasing responsibility across several DSM-owned businesses since 1996. He holds a master's degree in business economics from Erasmus University (Rotterdam, the Netherlands).

Robert F. Evans was previously Global Sales & Marketing Manager for DSM Dyneema since 2006. He has held a variety of marketing and sales positions with increasing responsibility across several DSM-owned businesses since 1996. He holds an MBA from the University of Southern Indiana (Evansville) and a bachelor's degree in chemistry from George Mason University (Fairfax, Va.).

About DSM PTG

Headquartered in Berkeley, Calif., DSM PTG specializes in the research, development, design, scale-up, and manufacture of new polymers, medical devices, and components. DSM PTG's operations of 70,000-square-feet comprise the equipment and expertise to support production-scale polymer synthesis through contract medical device manufacturing. In 2008 the company was acquired by Royal DSM N.V., the Netherlands-based global Life Sciences and Materials Sciences company. DSM Biomedical's guiding mission is to provide proprietary materials-based solutions that enable the replacement, repair, enhancement and ultimately the regeneration of tissue and organ function.

For more information:
DSM Biomedical
Tel. +31 (0)46 4763559
Info.Biomedical@dsm.com
footer for print stylesheet